Walleye Trading’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,000
| Closed | -$18.7K | – | 4543 |
|
|
2025
Q4 | $18.7K | Buy |
+10,000
| New | +$19.2K | ﹤0.01% | 4113 |
|
|
2024
Q3 | – | Sell |
-1,200
| Closed | -$1.64K | – | 4466 |
|
|
2024
Q2 | $1.64K | Buy |
+1,200
| New | +$2.42K | ﹤0.01% | 4085 |
|
|
2024
Q1 | – | Sell |
-124,300
| Closed | -$1.22M | – | 5174 |
|
|
2023
Q4 | $1.22M | Sell |
124,300
-9,500
| -7% | -$77.7K | ﹤0.01% | 2302 |
|
|
2023
Q3 | $1.12M | Sell |
133,800
-35,400
| -21% | -$405K | ﹤0.01% | 2282 |
|
|
2023
Q2 | $2.25M | Sell |
169,200
-12,300
| -7% | -$149K | 0.01% | 1567 |
|
|
2023
Q1 | $2.1M | Buy |
181,500
+33,400
| +23% | +$332K | ﹤0.01% | 1638 |
|
|
2022
Q4 | $1.21M | Buy |
148,100
+75,300
| +103% | +$649K | ﹤0.01% | 2083 |
|
|
2022
Q3 | $423K | Buy |
72,800
+19,900
| +38% | +$114K | ﹤0.01% | 3052 |
|
|
2022
Q2 | $234K | Sell |
52,900
-4,800
| -8% | -$29.2K | ﹤0.01% | 3571 |
|
|
2022
Q1 | $525K | Buy |
57,700
+50,400
| +690% | +$580K | ﹤0.01% | 2870 |
|
|
2021
Q4 | $149K | Sell |
7,300
-32,200
| -82% | -$777K | ﹤0.01% | 4133 |
|
|
2021
Q3 | $1.01M | Buy |
39,500
+13,700
| +53% | +$406K | ﹤0.01% | 2196 |
|
|
2021
Q2 | $902K | Buy |
25,800
+15,100
| +141% | +$439K | ﹤0.01% | 2247 |
|
|
2021
Q1 | $356K | Sell |
10,700
-3,800
| -26% | -$133K | ﹤0.01% | 3047 |
|
|
2020
Q4 | $376K | Buy |
14,500
+1,500
| +12% | +$25.5K | ﹤0.01% | 2928 |
|
|
2020
Q3 | $128K | Buy |
13,000
+7,400
| +132% | +$42.6K | ﹤0.01% | 3270 |
|
|
2020
Q2 | $19K | Sell |
5,600
-16,100
| -74% | -$54.8K | ﹤0.01% | 3993 |
|
|
2020
Q1 | $66K | Buy |
+21,700
| New | +$88.9K | ﹤0.01% | 3322 |
|
|
2017
Q2 | – | Sell |
-300
| Closed | -$2 | – | 4824 |
|
|
2017
Q1 | $2 | Sell |
300
-100
| -25% | -$489 | ﹤0.01% | 4543 |
|
|
2016
Q4 | $2K | Sell |
400
-21,300
| -98% | -$155K | ﹤0.01% | 4567 |
|
|
2016
Q3 | $194K | Sell |
21,700
-8,900
| -29% | -$74.4K | ﹤0.01% | 2830 |
|
|
2016
Q2 | $214K | Buy |
+30,600
| New | +$280K | ﹤0.01% | 2907 |
|
Other funds holding PACB
AIM
VCM
NAMA
